Background: Fanconi anemia (FA) is a rare genetic disorder characterized by genome instability, bone marrow failure, and cancer predisposition. Previously, small studies have reported heterogeneous immune dysfunction in FA.
INTRODUCTION
Fanconi anemia (FA) is a rare genetic disorder characterized by genome instability, progressive bone marrow failure (BMF) and predisposition to malignancy, predominantly acute myeloid leukemia, and gynecological and head and neck squamous cell carcinomas. 1 The FA phenotype is the result of mutations in one of 20 known genes that function in the DNA interstrand cross-link repair pathway, 2,3 leading Better understanding of immune function in individuals with FA is critical to advancing our comprehension of differences in viral susceptibility and/or response, as well as immune surveillance with regard to neoplastic cells in this population with known predisposition to DNA damage and malignancy. The effects of age or disease status must also be explored. We present a comprehensive assessment of immune function in a cohort of young children and adults with FA, compared to healthy age-matched controls.
METHODS

Study participants and characteristics
Patients with a confirmed diagnosis of FA (by diepoxybutane test- 
Health survey
Health surveys were administered by using the Research Electronic Data Capture system. 7 The survey collected demographic, socioeconomic, clinical, sexual history, lifestyle, and environmental exposure information. Participants aged 15 years and older were asked to complete surveys for themselves unless they were physically or mentally unable to do so, in which case a parent or guardian was asked to complete the survey on their behalf. For younger children, particularly those less than 12 years old, a parent/guardian was asked to complete the survey for participating children.
Blood collection and processing
Approximately 90% of blood samples were collected at the FACCC and 
Immune assays
Participant peripheral blood samples were tested for lymphocyte subsets, B-cell panel, and immunoglobulin levels (IgG, IgM, IgE, and IgA) along with tetanus and diphtheria titers. In addition, NK function, CTL function, intracellular and plasma cytokines, T-cell receptor (TCR)-alpha/beta, and TCR-gamma/delta populations, as well as antigen and mitogen stimulation, were tested. Immunoglobulin levels (IgG, IgM, IgE, and IgA) levels were determined by standard methods in the CCHMC Clinical Laboratory. Tetanus and diphtheria titers were determined by Quantitative Multiplex Bead Assay at ARUP Laboratories.
Remaining assays were performed at CCHMC Diagnostic Immunology Laboratory as previously described. 6 Results were interpreted with respect to age-appropriate reference ranges established in the laboratories.
Analysis of intracellular cytokines was performed as mentioned in previously published studies. 8 
Immunophenotypic analysis of B-cell maturation in bone marrow
Bone marrow aspirates were processed for flow cytometric immunophenotyping using a standardized approach. 10 Percentages of these B-cell stages were calculated based on total events divided by events in each B-cell stage and multiplied by 100.
TA B L E 1 FA study population
Characteristics
All subjects (N = 29) <10 years (N = 12) ≥10 years (N = 17) P-value Age was shown as median (IQR) and compared using Wilcoxon rank sum test; all other characteristics were shown as proportions and tested using a Fisher's exact test.
Oral sample collection and human papilloma virus testing
Oral-rinse and gargle samples were collected in 15 ml saline and processed as previously described. 11 DNA was isolated using the 5 Prime t-test to test whether the z scores of the FA patients were lower than 0, which are the expected mean z scores of the non-FA population. We performed age-based comparisons, in which age was dichotomized into <10 years versus ≥ 10 years groups, or <18 years (pediatric)
versus ≥18 years (adult) groups. Ten years of age was selected based on the average age of bone marrow transplant at CCHMC over the last 5 years. All statistical analyses were performed using SAS, version 9.3.
A P value ≤ 0.05 was used to indicate statistical significance.
RESULTS
Study population
Baseline demographics and disease characteristics for the entire cohort of 29 patients as well as age group specific data are described in Table 1 . Twenty-nine individuals with FA completed the baseline survey and provided blood for immune testing. The median age for all participants was 12 years (range 2-47). Twelve of the 29 subjects were under the age of 10 years and 22 participants were 18 years or younger.
None of the participants had a history of cancer or had received a bone marrow transplant at the time of enrollment. No participants had severe BMF at baseline. Additionally, 52% were male, 41% were complementation group A, and 34% had other complementation groups, while 24% did not yet know their complementation group. There were no statistically significant differences in demographics between the younger and the older groups. Overall, there were considerable differences in the immune parameters observed across participants with FA with most being significantly reduced after considering typical differences related to normal growth and development by age ( Figs. 1 and 2 ).
Across the immune parameters studied, however, there were no differences observed by marrow failure status.
T lymphocytes
Subjects with FA had fewer absolute CD4 + T cells (z = -1.41; P < 0.001) than the non-FA population, but absolute CD3 + total T cells (z = -0.02; P = 0.47) and CD8 + T cells (z = 0.49; P = 0.98) did not significantly differ ( Fig. 1 and Table 2 ). In general, CD8 + T cells did not F I G U R E 1 Quantitative immune assays. Age-specific z scores of each of the quantitative immune assays were shown as dots for the FA individuals. The lines showed the regression of the immune assay with age in the young and old age groups. The mean z scores of all the FA individuals were presented, and P values indicated the differences between FA to the non-FA population
TA B L E 2 Quantitative immune assays
Immune assay FA mean z-scores (SD) P-value For z scores, the Ha is <0; a P-value < 0.05 (in bold) indicates that the z score is lower than the expected population mean of 0.
statistically differ from normal subjects (P = 0.98), a significant difference was observed between individuals with FA who were less than 10 years old and those that were older than 10 years (P = 0.004). Older subjects tended to have greater absolute CD8 + T cells than normal subjects, while younger children commonly were similar to normal children or were more likely to have lower CD8 + values (Fig. 1) . T-cell proliferation in response to antigen was reduced in individuals with FA in response to C. albicans (19% abnormal; P = 0.019) and tetanus (19% abnormal; P = 0.019), but not to PHA (P = 0.64). CTL function was also significantly reduced in those with FA (24% abnormal; P = 0.003) ( Fig. 2 and Table 3 ).
B lymphocytes
Absolute CD19 + B cells (z = -1.41; P < 0.001) and CD19 + /CD27 + memory B cells (z = -0.98; P < 0.001) numbers were significantly reduced ( Fig. 1 and Table 2 ). Concomitant immunophenotypic examination of 15 available marrow samples revealed a strong positive correlation (r = 0.96) between the mature marrow B-cell population and CD19 + B cells, suggesting a similarity between peripheral blood and bone marrow populations. IgM levels were significantly diminished in FA individuals (P < 0.001), whereas IgG levels were not statistically lower ( Fig. 2 and Table 3 ).
NK cells
Absolute CD16 + NK cells were also significantly diminished in FA (z = 0.92; P < 0.001) (Figs. 1 and 2) . Importantly, 16% of FA individuals with normal levels of NK cells had reduced NK-cell function (P = 0.07; Fig.   2 and Table 3 ), suggesting that function may be impaired even in those with normal NK levels. Analysis of intracellular and plasma cytokines F I G U R E 2 Functional immune assays. Six immune assays for each of the FA individuals were categorized into high, normal, and low and shown as dots. The proportions of low in the FA patients were presented, and P values indicated the differences in the low% between FA and the non-FA population
TA B L E 3 Functional immune assays in FA individuals
Immune assay N % abnormal in FA P-value Data are shown as proportions of subjects who had low immune function comparing with clinical cutoff values (5% percentiles of a normal population). A P-value < 0.05 (in bold) indicates that the proportion of subjects with low measures is higher than 5%, which is expected to be observed in a normal population; NK lytic units are measured in those (N = 19) with normal NK cell numbers.
(IL1b, IL2, IL4, IL6, IL8, IL10, IFN-, TNF-, and GM-CSF) did not reveal significant differences between our FA population and controls.
Infections
Review 
DISCUSSION
Immune dysfunction is known to occur in individuals with FA, but has not been well characterized, especially in those with less severe BMF.
Our study examined quantitative and functional aspects of immune function in a relatively young cohort of individuals with FA without advanced marrow failure or history of malignancy, and used more detailed testing than prior studies including the use of age-specific references to control for immune function variations in response to growth and development. Consistent with our previous work, we confirm decreases in number and function of B and NK cells despite overall less severe marrow disease. 6 We also report a previously unre- 
